Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

In the letters, Trump gave the pharmaceutical firms until Sept. 29 to make a series of commitments that aim to provide “immediate relief from the vastly inflated drug prices and put an end to the free ...

A normally hard-headed bench just endorsed President Biden’s scheme to dictate how much drugmakers can charge under Medicare.

Federal judges in Texas and Connecticut on Thursday ruled against arguments challenging the constitutionality of the Medicare ...

The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere to ...

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...

Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.

The Trump administration is launching a pressure campaign against prescription drugmakers in an effort to get them to lower ...

Trump’s first-term rule—“Most Favored Nation”—was focused on lowering the cost of Medicare payments on certain drugs, but the ...

PFIZER said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.

Over the past few weeks, major health insurers reported their mid-year earnings, and the results have been largely mixed.

As prescription drug prices continue to rise, many patients are left wondering how their costs are determined.